The role of naïve T-cells in HIV-1 pathogenesis: an emerging key player

Clin Immunol. 2011 Dec;141(3):253-67. doi: 10.1016/j.clim.2011.09.002. Epub 2011 Sep 17.

Abstract

Functional naïve T-cells are critical for an effective immune response to multiple pathogens. HIV leads to a significant reduction in CD4+ naïve T-cell number and impaired function and there is incomplete recovery following combination antiretroviral therapy (cART). Here we review the basic homeostatic mechanisms that maintain naïve CD4+ T-cells and discuss recent developments in understanding the impact of HIV infection on naïve CD4+ T-cells. Finally we review therapeutic interventions in HIV-infected individuals aimed at specifically enhancing recovery of naïve CD4+ T-cells.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-HIV Agents / therapeutic use
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / virology
  • Chemokines / immunology
  • Clinical Trials as Topic
  • Dendritic Cells / immunology
  • Dendritic Cells / virology
  • HIV Infections / drug therapy
  • HIV Infections / immunology*
  • HIV Infections / virology
  • HIV-1 / immunology*
  • Humans
  • Interleukin-2 / immunology
  • Interleukin-2 / therapeutic use
  • Interleukin-7 / immunology
  • Interleukin-7 / therapeutic use
  • Mice
  • Receptors, Antigen, T-Cell / immunology
  • Receptors, Interleukin-7 / immunology

Substances

  • Anti-HIV Agents
  • Chemokines
  • Interleukin-2
  • Interleukin-7
  • Receptors, Antigen, T-Cell
  • Receptors, Interleukin-7